Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2021-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
사업보고서 (2020.12)
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report' (감사보고서) for Bioneer Corporation, covering the fiscal year 2020. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. It is not an Annual Report (10-K) as it lacks the comprehensive management discussion and analysis (MD&A) and business overview typical of a full 10-K, and it is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2020
2021-03-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items, and instructions for electronic voting. This falls under the category of Proxy Solicitation & Information Statement.
2021-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Bioneer Corporation. It contains the meeting date, location, agenda items (financial statements, director appointments, etc.), and information regarding electronic voting. This is a standard proxy solicitation document sent to shareholders to inform them of an upcoming meeting and request their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2021-03-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details specific share transactions (buy/sell) by an individual (Chae Myeong Yun) who is an executive of Bioneer Corp. This type of filing is a standard regulatory disclosure for insider trading/share ownership changes, which corresponds to the 'Director's Dealing' category.
2021-03-09 Korean
연결재무제표기준영업(잠정)실적(공정공시)(월별)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) filed by Bioneer. It provides key financial highlights (revenue, profit, etc.) for a specific period (January-February 2021) to investors. It is a standard earnings announcement rather than a full report, fitting the definition of an Earnings Release (ER). Q1 2021
2021-03-04 Korean
[기재정정]연결재무제표기준영업(잠정)실적(공정공시)(월별)
Earnings Release Classification · 100% confidence The document is a regulatory filing from Bioneer regarding a correction to previously disclosed preliminary financial results (Earnings Release). It explicitly mentions '연결재무제표 기준 영업(잠정)실적' (Preliminary Financial Results based on Consolidated Financial Statements) and provides a correction to the percentage change compared to the previous period. Since this is an initial announcement of financial performance (even if it is a correction to a previous release), it falls under the Earnings Release category. Q1 2021
2021-03-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.